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Abstract
Whole-cell patch-clamp and extracellular field recordings were obtained from 450-μm-thick brain
slices of infant rats (10–13 days postnatal) to determine the actions of corticotropin-releasing
hormone on glutamate- and GABA-mediated synaptic transmission in the hippocampus. Synthetic
corticotropin-releasing hormone (0.15 μM) reversibly increased the excitability of hippocampal
pyramidal cells, as determined by the increase in the amplitude of the CA1 population spikes
evoked by stimulation of the Schaffer collateral pathway. This increase in population spike
amplitude could be prevented by the corticotropin-releasing hormone receptor antagonist α-helical
(9–41)-corticotropin-releasing hormone (10 μM). Whole-cell patch-clamp recordings revealed
that, in the presence of blockers of fast excitatory and inhibitory synaptic transmission,
corticotropin-releasing hormone caused only a small (1–2 mV) depolarization of the resting
membrane potential in CA3 pyramidal cells, and it did not significantly alter the input resistance.
However, corticotropin-releasing hormone, in addition to decreasing the slow
afterhyperpolarization, caused an increase in the number of action potentials per burst evoked by
depolarizing current pulses. Corticotropin-releasing hormone did not significantly change the
frequency, amplitude or kinetics of miniature excitatory postsynaptic currents. However, it
increased the frequency of the spontaneous excitatory postsynaptic currents in CA3 pyramidal
cells, without altering their amplitude and single exponential rise and decay time constants.
Corticotropin-releasing hormone did not change the amplitude of the pharmacologically isolated
(i.e. recorded in the presence of GABAA receptor antagonist bicuculline) excitatory postsynaptic
currents in CA3 and CA1 pyramidal cells evoked by stimulation of the mossy fibers and the
Schaffer collaterals, respectively. Current-clamp recordings in bicuculline-containing medium
showed that, in the presence of corticotropin-releasing hormone, mossy fiber stimulation leads to
large, synchronized, polysynaptically-evoked bursts of action potentials in CA3 pyramidal cells.
In addition, the peptide caused a small, reversible decrease in the amplitude of the
pharmacologically isolated (i.e. recorded in the presence of glutamate receptor antagonists)
evoked inhibitory postsynaptic currents in CA3 pyramidal cells, but it did not significantly alter
the frequency, amplitude, rise and decay time constants of spontaneous or miniature inhibitory
postsynaptic currents.
These data demonstrate that corticotropin-releasing hormone, an endogenous neuropeptide whose
intracerebroventricular infusion results in seizure activity in immature rats, has diverse effects in
the hippocampus which may contribute to epileptogenesis. It is proposed that the net effect of
corticotropin-releasing hormone is a preferential amplification of those incoming excitatory
signals which are strong enough to reach firing threshold in at least a subpopulation of CA3 cells.
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These findings suggest that the actions of corticotropin-releasing hormone on neuronal excitability
in the immature hippocampus may play a role in human developmental epilepsies.
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The neuropeptide corticotropin-releasing hormone (CRH) may play an important role in
seizure disorders of the developing brain. For example, massive infantile spasms, a
particularly devastating and common form of pediatric epilepsy,1,14 respond to
adrenocorticotropic hormone, an agent which decreases the levels of CRH in the central
nervous system.4 Recent evidence suggests that CRH may also play a central role in the
generation of febrile seizures.9 Intracerebroventricular infusion of CRH results in seizures in
young rats, whereas CRH-induced seizures are considerably less prominent in adult animals
compared to infant rats.5,8,13,18 The CRH-induced seizures can be prevented by blocking
CRH receptors.8 Receptors for CRH are found in brain areas known for their involvement in
seizures, including the hippocampus, neocortex and amygdala.12 In addition, CRH-
containing cells and axons are also present in these brain regions.7,22,29 Of particular interest
is the CA3 region of the hippocampus, where CRH receptor mRNA is highly abundant
during early postnatal life,3 and CRH results in pyramidal cell damage in the CA3 subfield.6
The hippocampus is likely to play an important role in the generation of CRH-induced
limbic seizures18 and/or in the propagation of seizures which originate elsewhere, e.g., in the
amygdala.5,13
In contrast to the considerable evidence implicating CRH in developmental seizures, our
knowledge of the cellular–synaptic mechanisms involved in the generation of CRH-induced
seizures is rather limited. Intracellular electrophysiological recordings carried out with sharp
microelectrodes have shown that CRH decreases the slow afterhyperpolarization (AHP)
following a burst of action potentials evoked by intracellular injection of depolarizing
current in CA1 and CA3 pyramidal cells,2,23,24 as well as in the basolateral nucleus of the
amygdala21 and in Purkinje cells of the cerebellum.15 In a recent study, Smith and Dudek24
demonstrated that CRH (0.2 μM) caused a 28% increase in the amplitude of the population
spike in the CA1 region. This effect of CRH was larger in infant rats than in adults, and
persisted in the presence of the GABAA receptor antagonist bicuculline.24 In the present
study, we used whole-cell patch-clamp recording techniques in vitro to investigate the
effects of CRH on synaptic transmission in the infant rat hippocampus.
EXPERIMENTAL PROCEDURES
Preparation of slices
The preparation of slices from infant rats was done as described previously for the
adult.28,25 Briefly, 10- to 13-day-old Sprague–Dawley rats (Simonsen Laboratories Inc.,
Gilroy, CA, U.S.A.) were decapitated under halothane anesthesia and the brains were
removed. Brains were cooled in 4°C artificial cerebrospinal fluid (ACSF), composed of (in
mM): 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4 and 10 glucose.
Horizontal whole brain slices27 (450 μm) were prepared with the use of a Vibratome tissue
sectioner (Lancer Series 1000). The brain slices were sagittally bisected into two
hemispheric components and preincubated submerged in a temporary storage chamber
containing oxygenated ACSF at 32°C for 1 h before any experimental manipulations.
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Electrophysiology
Electrodes and solutions—Patch pipettes were pulled from boroscilicate (KG-33) glass
capillary tubing (1.5 mm o.d.; Garner Glass) with a Narishige PP-83 two-stage electrode
puller. Tip dimensions were 0.5–1.0 μm inner diameter and 3–4 μm outer diameter. The
intracellular solutions were made in high-performance liquid chromatography grade water
(Omnisolve, EM Science). To record excitatory or inhibitory postsynaptic currents (EPSCs
or IPSCs respectively), the intracellular solution consisted of (in mM): 140 cesium gluconate
or CsCl, 2 MgCl2, 10 HEPES, 2 ATP (Sigma) and 11 EGTA (Sigma), and for spontaneous
inhibitory currents, 3 mM QX-314; the pH was adjusted with CsOH to a final value of 7.20–
7.25. The osmolarity of the intracellular solutions ranged between 255 and 270 mOsm. The
solutions were filtered through a 0.2-μm pore size filter (Nalgene) before filling the pipettes.
For extracellular field recordings, patch electrodes were filled with ACSF. All salts were
obtained from Fluka.
Recordings—For electrophysiological recordings, the slices were transferred to the
recording chamber perfused with ACSF containing the appropriate drugs for each
experiment (as described below). Slices rested on filter paper and were stabilized with
platinum wire weights. Slices were continuously superfused with warm, humidified
95%O2+5%CO2, and the temperature of the perfusion solution was maintained at 36°C. The
application of the “blind” whole-cell recording technique to the standard brain slice
preparation has been described in detail.10,28 Recordings were obtained with an Axopatch
200A amplifier (Axon Instruments), or with a Neurodata two-channel intracellular amplifier
(Cygnus Technology), and digitized at 88 kHz before being stored on videotape.
To elicit orthodromic field potential responses in the CA1 region of the hippocampus,
current pulses were delivered through a bipolar stimulating electrode placed in the stratum
radiatum of CA1. CRH (Bachem, Torrance, CA, U.S.A.) was included in the perfusing
solution and was bath applied. Whole-cell recordings of spontaneous, miniature and evoked
synaptic currents were obtained from CA3 (and in some cases CA1) pyramidal cells in slices
perfused with the appropriate solution with or without CRH: (i) for field recordings and
spontaneous EPSCs (sEPSCs): control ACSF; (ii) for evoked EPSCs (eEPSCs): ACSF and
20 μM bicuculline methiodide (BMI; Research Biochem. Int.); (iii) for miniature EPSCs
(mEPSCs): ACSF, BMI and 1 μM tetrodotoxin (TTX; Calbiochem); (iv) for spontaneous
IPSCs (sIPSCs) and evoked IPSCs (eIPSCs): ACSF and 10 μM 2-amino-5-phosphovaleric
acid (APV; Tocris)+5 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris); (v) for
miniature IPSCs (mIPSCs): ACSF containing APV, CNQX and TTX. During the
recordings, the series resistance (Rs) was closely monitored, and data were rejected if the Rs
changed significantly or if it exceeded 16 MΩ.
Analysis—The recordings were filtered at 3 kHz before digitization at 20 kHz by computer
(National Instruments LabPC+A/D board in a Pentium 90 MHz personal computer). To
digitize and analyse the data, Strathclyde Electrophysiology software (courtesy of Dr J.
Dempster) and Synapse software (courtesy of Dr Y. De Koninck) were used. Detection of
individual spontaneous and miniature synaptic events was achieved using a software trigger
described previously.20,26 For each experiment, all detected events were examined; any
noise that spuriously met trigger specifications was rejected. A least-squares Simplex-based
algorithm was used to fit the ensemble average with the sum of two (one rising and one
decaying) exponentials:
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where I(t) is the synaptic current as a function of time (t), A is a constant, and τr and τD are
the rise and decay time constants, respectively. Statistical analyses (t-test or F-test) were
performed using SPSS for Windows or Sigma Plot, with a level of significance of P≤0.05.
Data are presented as means ± S.E. (n is number of cells).
RESULTS
Corticotropin-releasing hormone reversibly increases the evoked population discharges of
hippocampal principal cells
First, experiments were conducted to determine whether CRH increased the population
responses in the CA1 region of immature rats. As Fig. 1 demonstrates, CRH (0.15 μM)
reversibly increased the population spike in CA1 following the first (asterisk in Fig. 1), as
well as the second, stimulus of paired stimuli delivered to the Schaffer collateral pathway
[Fig. 1; the paired-pulse protocol was employed to improve the ability to measure the
increase in the population spike amplitude, since the population spike is usually small
following the first stimulus in our slices in control medium (i.e. without BMI), because of
the prominent feed-forward inhibition; for a detailed discussion, see Ref. 17. The increase in
the population spike (123.6±5.9% of control; n=3) was significant (P<0.05), and comparable
to that reported by Smith and Dudek.24 Although CRH increased the population spikes,
multiple discharges were not observed.24
In a separate series of experiments, the effect of the CRH receptor antagonist α-helical (9–
41)-CRH (10 μM) was tested on the CRH-induced enhancement of the population spikes.
CRH failed to increase the amplitude of the CA1 population spikes in the presence of CRH
receptor antagonist (n=3), indicating that CRH increases neuronal excitability via CRH
receptors.
Corticotropin-releasing hormone increases the intra-cellularly evoked burst firing in CA3
pyramidal cells, but it does not induce action potential firing when cells are at rest
Next, whole-cell patch-clamp experiments were conducted in CA3 pyramidal cells in
current-clamp mode. The field recording experiments described above were conducted in
CA1, to compare our data with those of Smith and Dudek,24 and also because in infant rats
the field potentials are considerably more robust and reliable in CA1 than in CA3. However,
recent in situ hybridization data clearly showed that, within the hippocampus of infant rats,
it is the CA3 region which contains the highest density of CRH receptor mRNA.3 Because
of these data, in addition to the sensitivity of CA3 cells to CRH-induced seizures,6 and the
known role of the CA3 region in seizure generation,30 most of the whole-cell patch-clamp
data reported in this paper were obtained from CA3 pyramidal cells.
In the presence of BMI, APV, and CNQX, CRH caused only a small (1–2 mV) positive shift
in the resting membrane potential (Vm) of the whole-cell recorded CA3 pyramidal cells
(pipette solution: potassium gluconate; n=5; cells were switched from control to CRH;
control Vm before CRH application: −62.2±1.83 mV; Vm in the presence of CRH:
−61.2±2.01 mV; note that although the means of the five pre-CRH Vm values and the means
of the post-CRH Vm values appear to be similar, a paired t-test showed that the difference
was significant; P<0.05). However, the small CRH-induced depolarization did not reach
firing threshold in any of the cells. Therefore, CRH is unlikely to induce hyper-excitability
in vivo8 by depolarizing the Vm and increasing the baseline spontaneous firing rate of CA3
cells.
However, in agreement with Aldenhoff et al.,2 CRH caused a significant increase in the
number of spikes in a burst evoked by a depolarizing current pulse (n=3 cells; the number of
action potentials during the first 250 ms during the depolarizing current pulse in control
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ACSF: 2.93±0.13; in the presence of CRH: 4.36±0.23), indicating that if a strong
depolarizing influence and action potential firing are already present in the network, CRH
can enhance excitability by increasing the number of action potentials that the cell emits in
response to a given depolarizing input. Furthermore, as shown before,2,23,24 CRH decreased
the slow AHP in the same cells. However, CRH did not change the input resistance (RIN;
measured using hyperpolarizing responses from −75 mV in voltage clamp) of the CA3
pyramidal cells (n=7; control RIN: 173.53±26.3 MΩ RIN in CRH: 154.18±12.56 MΩ).
Therefore, CRH does not in itself cause cells to fire, but if the neurons are brought to firing
threshold by a depolarizing influence [e.g., an intracellular depolarizing current pulse or an
excitatory postsynaptic potential (EPSP); see below], CRH can increase the number of
action potentials and contribute to the spread of excitability in the network.
Effect of corticotropin-releasing hormone on spontaneous excitatory synaptic
transmission in CA3 pyramidal cells
Next, sEPSCs were recorded with cesium gluconate-filled patch pipettes in control ACSF in
CA3 pyramidal cells held at −60 mV (i.e. close to the reversal potential for sIPSCs, which
we determined in each cell by establishing the membrane potential at which the high-
frequency outward events, i.e. the sIPSCs, disappeared as the membrane potential was
hyperpolarized from 0 mV). Under these conditions, sEPSCs appear as transient inward
currents. Application of CRH significantly increased the frequency of the sEPSCs in six of
seven cells, by 252.82±65.09% on average (Fig. 2; average control sEPSC frequency in the
six cells in which CRH did increase the sEPSC frequency: 1.95±0.69 Hz; in the presence of
CRH: 5.07±2.02; average control sEPSC frequency in all seven cells: 2.57±0.85 Hz; in the
presence of CRH: 5.18±1.71 Hz). The increase in frequency was fully reversible after
switching back to control solution (Fig. 2C). The CRH-induced change in frequency was not
accompanied by a change in sEPSC amplitude (control: 39.05±3.92 pA; CRH: 43.32±4.67
pA; n=6) or kinetics (rise time constants: control, 1.08±0.16 ms; CRH, 1.38±0.16 ms; decay
time constants: control, 6.69±0.75 ms; CRH, 7.02±0.84 ms; n=6).
Corticotropin-releasing hormone has no effect on the frequency, amplitude and kinetics of
miniature excitatory postsynaptic currents
The next series of experiments were aimed at determining whether CRH increases excitatory
neurotransmission in the absence of action potentials. To achieve this goal, mEPSCs were
recorded in the presence of the sodium channel blocker TTX, and BMI, with cesium
gluconate electrodes, at −60 mV. No significant increase in the frequency of mEPSCs
occurred when the control medium was switched to a medium containing CRH (control:
3.9±3.1 Hz; CRH: 5.3±4.3; n=5). When mEPSCs were compared in CA3 cells from slices
bathed in either control ACSF or in CRH, the frequency of mEPSCs was also not
significantly different (control: 2.2±1.4, n=11; CRH: 3.7±2.2, n=10). CRH did not alter the
amplitude (control: 23.5±1.6 pA, n=5; CRH: 21.9±1.7 pA; n=8), rise (control: 1.0±0.14 ms,
n=5; CRH: 0.99±0.13 ms, n=8) or decay time constants (control: 7.2±0.86 ms, n=5; CRH:
6.8±0.67 ms, n=8) of mEPSCs, indicating the lack of a direct postsynaptic action of CRH on
glutamate receptors.
Corticotropin-releasing hormone does not alter the amplitude of evoked monosynaptic
excitatory post-synaptic currents, but it can enhance the polysynaptic excitatory response
In the next series of experiments, the effect of CRH on the eEPSCs was determined. In the
presence of BMI, CRH failed to alter the amplitude of the eEPSCs (Fig. 3A) evoked by
stimulation of the mossy fiber pathway in CA3 cells (n=7; the amplitude of the eEPSCs was
106.87±16.01% of control). Similarly, CRH did not change the amplitude of the eEPSCs in
CA1 pyramidal cells evoked by stimulation of the Schaffer collaterals, in slices in which the
CA1 and CA3 regions were separated by a knife-cut in order to eliminate the spread of the
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BMI-induced epileptiform activity from CA3 to CA1 (n=4; Fig. 3A). These results are in
agreement with the lack of CRH effects on the amplitude of the sEPSCs, and they indicate
that CRH does not alter the action potential-induced release of glutamate.
Taken together, the data presented above suggest that CRH does not cause large
depolarizations and induce action potential firing, does not alter post-synaptic glutamate
receptors, and has no effect on the action potential-induced glutamate release, but the
peptide can enhance the number of action potentials in a burst evoked by intracellular
injection of depolarizing current pulses and increase the frequency of sEPSCs. Based on
these data, it seems reasonable to suggest that although CRH by itself (i.e. when cells are at
rest) cannot cause hyperexcitability (e.g., synchronized burst firing), it may enhance
excitability when a depolarizing input is provided to bring at least some cells to firing
threshold. Therefore, we tested this hypothesis by recording from CA3 pyramidal cells in the
presence of BMI in current-clamp mode, and stimulated the mossy fiber pathway. If the
hypothesis is correct, CRH should not alter the short-latency, monosynaptic EPSPs;
however, provided that the stimulus can evoke firing, at least in some CA3 cells (perhaps
occasionally also aided by the CRH-induced increase in the frequency of the randomly
occurring sEPSCs), CRH may lead to burst firing at longer latencies in CA3 cells following
stimulation of the mossy fiber pathway. Indeed, as shown in Fig. 3B, when the mossy fiber-
evoked responses were recorded from CA3 pyramidal cells in current-clamp mode in the
presence of BMI, CRH caused the appearance of large bursts of action potentials at variable
latency, even though the amplitude of the monosynaptic EPSP did not change. The bursts of
action potentials appeared to be elicited by longer-latency and most likely polysynaptic
EPSPs. Upon switching back to the control solution, recovery could be obtained (in fact, in
the cell shown in Fig. 3B, the effect of CRH could be repeated twice with full recovery).
Therefore, similar to the ability of CRH to increase the number of action potentials in an
intracellularly evoked burst, CRH can cause hyperexcitability in the network, provided that
some excitatory influence (in this case provided by stimulation of the mossy fibers) is
already present. In other words, CRH appears to amplify excitatory inputs, but it cannot
cause hyperexcitability without them.
Corticotropin-releasing hormone’s actions on inhibitory synaptic currents in CA3 cells
Next, we tested the effects of CRH on inhibitory synaptic transmission. In contrast to its
action on sEPSCs, CRH did not significantly alter the frequency of sIPSCs, recorded in the
presence of the glutamate receptor antagonists APV+CNQX, with CsCl-filled pipettes at
−60 mV (sIPSC frequency in CA3 cells from slices incubated in control ACSF: 44.7±4.2
Hz, n=12; in cells incubated in CRH-containing medium: 34.5±5.0 Hz, n=13). Similarly,
CRH did not alter the frequency of sIPSCs in cells where the perfusate was switched from
control ACSF+APV+CNQX to ACSF+APV+CNQX+ CRH (Fig. 4A, B; n=2). Next, the
effect of CRH on mIPSCs was tested, in ACSF containing APV+CNQX+TTX, at −60 mV
with CsCl-filled pipettes. In three cells where the perfusate was switched from ACSF
containing APV+CNQX+TTX to the same solution with added CRH, no significant
alteration was found in the frequency (control: 1.3±s0.7 Hz; CRH: 0.7±0.2 Hz), rise time
constant (control: 0.8±0.1 ms; CRH: 0.7±0.1 ms), decay time constant (control: 7.5±0.6 ms;
CRH: 8.5±0.5 ms) or amplitude (control: 71.0±1.5 pA; CRH: 75.5±8.1 pA) of mIPSCs in
CA3 pyramidal cells. However, as shown in Fig. 4C, CRH was able to cause a small but
significant and reversible decrease in the amplitude of eIPSCs evoked in the presence of
APV and CNQX by a stimulating electrode placed in the CA3 pyramidal cell layer (control
eIPSC amplitude: 2.16±0.69 nA; eIPSC amplitude in the presence of CRH: 1.59±0.56 nA; a
28.6% decrease, n=5; P<0.05, paired t-test). These data indicate that CRH may induce a
relatively small decrease in the action potential-induced release of GABA, but it has no
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effect on the postsynaptic GABAA receptors, or on the properties of the action potential-
independent GABA release.
DISCUSSION
The main findings of this paper are that: (i) CRH causes a small depolarization of the
membrane potential in CA3 cells, but the CRH-induced depolarization is not suffcient to
bring cells to firing threshold; (ii) CRH, in addition to its known effect on the AHP,
increases the number of spikes evoked by intracellular depolarizing current pulses; (iii) CRH
increases the frequency of sEPSCs; (iv) CRH enhances polysynaptic burst firing in the
network in response to mossy fiber stimulation; and (v) CRH causes a small decrease in the
action potential-dependent GABA release. However, (vi) CRH has no direct postsynaptic
actions on glutamate or GABAA receptors mediating fast synaptic transmission, (vii) CRH
does not alter the amplitude of the evoked, monosynaptic EPSCs, and (viii) CRH does not
alter the action potential-independent glutamate and GABA release. These data suggest that
CRH, by amplifying excitatory inputs reaching the CA3 network, can induce pro-convulsant
effects within the CRH receptor-rich CA3 area, which may play an important role in the
propagation of seizures in the developing brain.
Corticotropin-releasing hormone-induced hyperexcit-ability in the hippocampus
It has been well documented that CRH administered to developing animals induces
seizures.5,8 Where these seizures originate is not clear at present. The
electroencephalographic studies of Marrosu et al.18 suggested that the primary site of
seizure-like electrical activity may be the hippocampus. However, recent evidence indicates
that CRH-induced seizures originate from the amygdala, and the seizures then spread to the
hippocampus.5,13 Our field recording results, in agreement with previous in vitro data,24
suggest that CRH alone does not lead to obvious seizure-like electrical population activity in
the hippocampus. On the other hand, the pro-convulsive actions of CRH in the hippocampus
reported in this paper are likely to augment seizure activity, originating either in the
hippocampus or elsewhere (e.g., in the amygdala), and subsequently spreading to the
hippocampal formation.
Cellular–synaptic mechanisms underlying corticotropin-releasing hormone-induced
hyperexcit-ability
Although it is clear that CRH induces seizures in infant animals, the mechanisms underlying
this phenomenon are not well understood. Previous investigations, all carried out with sharp
microelectrodes, determined that CRH reduces the AHP, resulting in an increased number of
spikes and increased burst duration in response to a pulse of depolarizing current.2,15,21,23,24
However, whether this effect of CRH on the AHP leads to increased excitatory synaptic
communication has not been studied in detail. Aldenhoff et al.2 noted that the frequency of
sub-threshold activity increased after CRH application, and Smith and Dudek24 found
variable effects of CRH on synaptic transmission in their study carried out with sharp
electrodes in CA1 pyramidal cells. We have employed high-resolution patch-clamp
techniques in CA3 pyramidal cells to study the synaptic effects of CRH in infant rats in
vitro.
Our data showed that CRH has a variety of potentially excitability-increasing effects on
single CA3 pyramidal cells in the hippocampus, including a small depolarization, a decrease
in AHP and an increase in evoked burst firing. These actions of CRH on the intrinsic
properties of CA3 cells do not, by themselves, lead to overt hyperexcitability (e.g., burst
firing) in the network. Similarly, CRH does not cause an increase in the monosynaptically
evoked EPSCs in either CA3 or CA1 cells. However, CRH is able to greatly amplify mossy
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fiber stimulation-evoked poly-synaptic excitability in the CA3 network (e.g., Fig. 3B), and it
can also increase the frequency of sEPSCs. Therefore, when some level of excitability is
present (either as a result of activation of excitatory inputs or spontaneous discharges of
pyramidal cells), CRH can lead to hyperexcitability, most likely via the increase in the
number of spikes that CA3 cells emit either in response to a depolarizing input or
spontaneously.
Although CRH can increase excitability even in the presence of BMI, as shown by Smith
and Dudek24 and by our data, CRH also has a clear, albeit small, effect on action potential-
mediated GABA release. Interestingly, although CRH decreases the monosynaptically
evoked GABAA response, it did not cause a significant decrease in the frequency of sIPSCs
(although there did appear to be a small, non-significant decrease, e.g., Fig. 4A, B). The
most plausible explanation for this seems to be that CRH may cause an increase in firing of
some interneurons, which may counteract the small decrease in the action potential-
dependent GABA release. Direct recording from various interneuronal populations19 will be
necessary to test this hypothesis. The possibility that some interneuronal classes may be
influenced by CRH is especially interesting in light of the observation that CRH may be
present exclusively in non-principal cells in the CA3 and CA1 fields,7 some of which may
innervate other interneuronal populations (for reviews, see Refs 11 and 16).
These data indicate that CRH has various pro-convulsant actions in the hippocampus, and
thus support the suggested role of CRH in certain non-genetic seizures of the developing
human.4,8 Endogenous CRH functions as a stress neurohormone, and a pathological increase
in CRH release is likely under circumstances of stress or insult to the developing central
nervous system. Such circumstances are associated with febrile seizures and infantile
spasms, seizures which are restricted to infancy and early childhood in human. Infantile
spasms, in particular, are eliminated by agents (such as adrenocorticotropic hormone) which
down-regulate CRH secretion.4 The current study demonstrates that CRH, especially in the
presence of depolarizing inputs, leads to increased excitability in the CA3 network. The
CRH-induced increase in action potential burst firing would enhance glutamate release in a
vicious circle that may contribute to epileptogenesis and/or to the degeneration of limbic
neurons, as has been observed after CRH administration in the developing rat.6
CONCLUSIONS
The data presented in this paper demonstrate that CRH has diverse pro-convulsant effects in
the hippocampus, and it is proposed that CRH amplifies incoming excitatory signals and
thus contributes to hyperexcitability. Future research will be necessary to determine the
precise molecular mechanisms involved in the various effects of CRH, the age dependence
of its actions,24 and the cellular identity and connectivity of CRH-containing neurons7 in
epilepsy-prone brain areas such as the hippocampus and the amygdala.
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Fig. 1.
CRH reversibly increases the evoked population spikes. Field recording in the CA1
pyramidal cell layer shows the response to a paired-pulse stimulus delivered to the Schaffer
collateral pathway in the stratum radiatum. Note that CRH (0.15 μM) caused the appearance
of a population spike (asterisk) following the first stimulus, and also increased the amplitude
of the population spike after the second stimulus. After washout of the drug, full recovery
could be obtained. Both the CRH effect and the washout occurred relatively rapidly, in 5–6
and 10–15 min, respectively (in our system BMI abolishes mIPSCs in 3 min).
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Fig. 2.
CRH reversibly increases the frequency of sEPSCs in CA3 pyramidal cells. (A) Whole-cell
recording in control ACSF, with cesium gluconate-filled electrodes at −60 mV (close to the
reversal potential of IPSCs), shows spontaneous EPSCs occurring at 5.2 Hz (as shown by
the inter-event interval distribution on the right) from a CA3 pyramidal cell. (B) Seven
minutes after switching to ACSF containing CRH (0.15 μM), the frequency of the sEPSCs
increased to 13.6 Hz. CRH caused a similar increase (253% on average) in sEPSC frequency
in six of seven cells. (C) The effect of CRH on sEPSC frequency was fully reversible.
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Fig. 3.
The effect of CRH on evoked excitatory responses in the presence of bicuculline. (A)
Voltage-clamp recording shows that CRH does not change the monosynaptically evoked
EPSCs in CA3 or CA1 cells following stimulation of the mossy fiber and the Schaffer
collateral pathway, respectively. (B) When the experiment was repeated in current-clamp
mode, CRH lead to large, synchronized polysynaptic discharges in CA3 cells following
mossy fiber stimulation. Note that the bursts have variable and long latency (indicating the
polysynaptic nature of the response), and they appear to rise from EPSPs, and that the
monosynaptic EPSP did not change in amplitude.
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Fig. 4.
CRH does not significantly alter the frequency of sIPSCs, but it causes a small decrease in
the amplitude of eIPSCs. (A) Examples of sIPSCs are shown, recorded in the presence of
APV+CNQX, at −60 mV with CsCl-filled pipettes from a CA3 pyramidal cell. As illustrated
by the inter-event interval distribution below, the frequency of sIPSCs was 70 Hz. (B) Nine
minutes after switching to a solution containing CRH (0.15 μM), there was no significant
change in the frequency of sIPSCs (61 Hz). (C) In CA3 pyramidal cells, CRH caused a
reversible, small (28.6%) decrease in the amplitude of IPSCs evoked by a stimulating
electrode placed in the pyramidal cell layer, in the presence of APV and CNQX.
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